Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Bio-Path Holdings, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −4 vs. Q3 2023
- Shares held
- 597.1K
- −97.2K (−14.0%) vs. Q3 2023
- Total value
- $276.5K
- +$19.8K (+7.7%) vs. Q3 2023
- New holders
- 3
- 5 more added
- Sold out
- 7
- 2 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $5 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 69 | $32 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 95 | $44 | 0.00% | +11+13.1% | Added |
| Bank of America Corp | 152 | $70 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 150 | $70 | 0.00% | +150 | New |
| Morgan Stanley | 700 | $324 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 5,500 | $2.55K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,723 | $4.50K | 0.00% | −9,028−48.1% | Reduced |
| State Street Corp | 13,033 | $6.03K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,400 | $7.13K | 0.00% | +378+2.5% | Added |
| HRT Financial LP | 17,294 | $8.00K | 0.00% | −629−3.5% | Reduced |
| Northern Trust Corp | 17,711 | $8.20K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 22,788 | $10.6K | 0.00% | +22,788 | New |
| Citadel Advisors LLC | 24,195 | $11.2K | 0.00% | +24,195 | New |
| Strategic Advocates LLC | 35,119 | $16.3K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 54,709 | $25.3K | 0.00% | +6,240+12.9% | Added |
| Geode Capital Management, LLC | 110,438 | $51.1K | 0.00% | +15,989+16.9% | Added |
| Vanguard Group Inc | 270,029 | $125.0K | 0.00% | +117,914+77.5% | Added |
| Walleye Capital LLC | 0 | $0 | 0.00% | −209,238−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −23,300−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −18,571−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| McClarren Financial Advisors, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |